Changes to the Roche Enlarged Corporate Executive Committee

Roche today announced that Michael Varney (1958) Ph.D., and Head of Genentech Research and Early Development (gRED) since 2015, will retire from the company at the end of July.

Source: Roche Media News - May 11, 2020 Category: Pharmaceuticals Source Type: news